FDA Occupational Safety, Industrial Hygiene, Information Systems, and Training (OSIST) IDIQ

Summary (Newest Update)

Background The U.S. Food and Drug Administration (FDA) is issuing Request for Proposal (RFP) No. 75F40126R00020 for Occupational Safety, Industrial Hygiene, Information Systems, and Training (OSIST) support services. The Government intends to award a single-award Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract to provide enterprise-wide Occupational Safety, Policy, Laboratory Quality, Industrial Hygiene, Information Systems, Training, and related support services across FDA headquarters and nationwide laboratory and field facilities. Work Details The IDIQ Performance Work Statement encompasses the following task areas: - Program and Order Management - Transition Services - Occupational Safety, Policy, and Laboratory Quality Support - Primary Barrier Equipment Maintenance and Certification - Industrial Hygiene Support Services - Information and Data Systems Support - Training Development and Management. Task Order 1 will include BSL-3 laboratory re-verification and certification support, primary barrier equipment certification validation, HVAC airflow and pressure differential testing, Vaporized Hydrogen Peroxide (VHP) decontamination services, biosafety compliance assessments aligned with CDC standards, deficiency identification and corrective action analysis, as well as preparation of verification reports and certification documentation. Period of Performance The ordering period for the resulting IDIQ contract will be five (5) years from the date of award. Place of Performance The primary place of performance for services under this IDIQ contract is FDA Headquarters – White Oak Federal Research Center located at 10903 New Hampshire Avenue, Silver Spring, MD 20993. Additional locations may be specified in individual task orders within the Washington DC metropolitan area or at other FDA nationwide facilities as required. Bidder Requirements Offerors must have relevant experience in occupational safety and industrial hygiene. All contractor personnel requiring access to FDA facilities must undergo background investigations conducted by the Defense Counterintelligence and Security Agency (DCSA). The Risk Designation for this contract is Tier 1. Contractors must comply with all FDA information security requirements including NIST cybersecurity framework standards. Incumbent Analysis (see Incumbents section for more detail) This opportunity appears to have a confirmed incumbent based on prior award 75F40120D00043, awarded to IHC for $4,991,443 (09/27/20–03/29/26). The prior work included safety engineering and industrial hygiene support for FDA laboratories, including maintenance and management of primary barrier equipment (e.g., biosafety cabinets and chemical fume hoods) and annual BSL-3 suite re-verification, along with related occupational health and safety, laboratory quality, and safety/security practices. The current OSIST IDIQ and initial task order similarly emphasize enterprise occupational safety/industrial hygiene support and BSL-3 re-verification/certification activities (including HVAC testing, VHP decontamination, and certification documentation), which suggests continuity of the same core safety and barrier certification functions.